These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationship between the liver and lymphocytotoxic alloantibodies in inbred rats. Specific absorption by nonparenchymal liver cells. Gugenheim J; Le Thai B; Rouger P; Gigou M; Gane P; Vial MC; Charpentier B; Reynes M; Bismuth H Transplantation; 1988 Feb; 45(2):474-8. PubMed ID: 3278442 [TBL] [Abstract][Full Text] [Related]
3. Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats. Gugenheim J; Amorosa L; Gigou M; Fabiani B; Rouger P; Gane P; Reynes M; Bismuth H Transplantation; 1990 Aug; 50(2):309-13. PubMed ID: 2200175 [TBL] [Abstract][Full Text] [Related]
4. Delayed rejection of heart allografts after extracorporeal donor-specific liver hemoperfusion. Role of Kupffer cells. Gugenheim J; Charpentier B; Gigou M; Cuomo O; Calise F; Amorosa L; Astarcioglu I; Trias i Folch M; Martin B; Bismuth H Transplantation; 1988 Mar; 45(3):628-32. PubMed ID: 3279586 [TBL] [Abstract][Full Text] [Related]
5. Delayed rejection of heart allografts in hypersensitized rats by extracorporeal donor-specific liver hemoperfusion. Gugenheim J; Houssin D; Emond J; Gigou M; Crougneau S; Bismuth H Transplantation; 1986 Mar; 41(3):398-400. PubMed ID: 3513399 [No Abstract] [Full Text] [Related]
6. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533 [TBL] [Abstract][Full Text] [Related]
7. The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat. Yamaguchi Y; Harland RC; Wyble C; Bollinger RR Transplantation; 1989 Jan; 47(1):171-7. PubMed ID: 2643224 [TBL] [Abstract][Full Text] [Related]
8. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts. Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247 [TBL] [Abstract][Full Text] [Related]
9. Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts. Furuya T; Murase N; Nakamura K; Woo J; Todo S; Demetris AJ; Starzl TE Hepatology; 1992 Dec; 16(6):1415-22. PubMed ID: 1446895 [TBL] [Abstract][Full Text] [Related]
10. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes. Majoor GD; Van Breda Vriesman PJ Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632 [TBL] [Abstract][Full Text] [Related]
11. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571 [TBL] [Abstract][Full Text] [Related]
12. [Spontaneous tolerance of liver allograft in the rat (author's transl)]. Houssin D J Chir (Paris); 1979 Nov; 116(11):663-74. PubMed ID: 400294 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression. Oluwole SF; Jin MX; Chowdhury NC; Ohajekwe OA Transplantation; 1994 Nov; 58(10):1077-81. PubMed ID: 7974714 [TBL] [Abstract][Full Text] [Related]
15. The alloantibody response and active enhancement of some rat renal allografts. Desi SB; Ruszkiewicz M Transplantation; 1977 Mar; 23(3):230-8. PubMed ID: 324043 [TBL] [Abstract][Full Text] [Related]
16. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions. Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895 [TBL] [Abstract][Full Text] [Related]
17. Suppression of rejection of organ allografts by alloantibody. Morris PJ Immunol Rev; 1980; 49():93-125. PubMed ID: 6445324 [No Abstract] [Full Text] [Related]
18. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization. Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525 [TBL] [Abstract][Full Text] [Related]
19. Probable antibody-mediated failure of two sequential ABO-compatible hepatic allografts in a single recipient. Ratner LE; Phelan D; Brunt EM; Mohanakumar T; Hanto DW Transplantation; 1993 Apr; 55(4):814-9. PubMed ID: 8475557 [TBL] [Abstract][Full Text] [Related]
20. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival. Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]